In a randomized cohort study of 128 cases of nasopharyngeal carcinoma, Beclin1 was associated with a poor prognosis 52, 53, and was consistent with our prognostic analysis at HNSC-TCGA. This evidence concerns the gene BECN1 and nasopharyngeal carcinoma.